在肝细胞癌中,PXMP2 抑制瘤干部和免疫透,基于干部风险
Dingde Ye1,2, Jiaqing Chen1,2, Jian Wang1
1Department of Hepatobiliary Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Discover oncology
|June 18, 2025
概括
这项研究根据茎状性确定了三种肝细胞癌 (HCC) 亚型. 基因PXMP2显示了瘤抑制作用,并预测了更好的预后,为向的HCC疗法提供了潜力.
科学领域:
- 在瘤学瘤学.
- 癌症干细胞生物学
- 免疫治疗是一种免疫疗法.
背景情况:
- 肝细胞癌 (HCC) 是复杂的,癌症干细胞 (CSCs) 驱动其进展和治疗耐药性.
- 了解HCC的茎状格局对于确定治疗点和预测患者反应至关重要.
研究的目的:
- 为了绘制HCC的茎状景观.
- 根据茎状性来识别HCC患者亚型.
- 发现免疫疗法反应的潜在生物标志物.
主要方法:
- 利用了来自StemChecker的26个干细胞基因组.
- 使用TCGA和GEO数据与生物信息学构建了一个干性风险模型.
- 在体外和体内验证的枢纽基因用于干性,TME相互作用和临床相关性.
主要成果:
- 确定了三种HCC亚型;C1呈现出不良预后,高茎风险和免疫抑制.
- 基因PXMP2表现出瘤抑制活性,抑制干细胞和调节免疫细胞透 (M1与M2巨细胞,中性粒细胞).
- 高PXMP2表达与有利的HCC患者预后相关.
结论:
- 建立了三种不同的基于茎状的HCC亚型.
- 开发了一种新的三基因预后风险模型,用于HCC.
- PXMP2是HCC生物学中的关键因素,为个性化免疫疗法和化疗提供了潜在的治疗标.
相关概念视频
02:23Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
02:40Cancer Stem Cells and Tumor Maintenance
5.1K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.1K